OtherResearch profile

Dermorphin

H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 · [D-Ala2]-Dermorphin

Think of it as nature's ultra-powerful pain reliever.

Dermorphin is a peptide that packs a punch when it comes to pain relief. Originally discovered in the skin of South American frogs, this compound is a heavyweight in the opioid world. Imagine it as a supercharged version of morphine, but with a twist. It works by latching onto specific receptors in the brain, much like a key fitting into a lock, to dull pain sensations.

What sets dermorphin apart is its ability to cross into the brain more efficiently than some other natural pain relievers. In animal studies, it shows a remarkable capacity to ease pain without causing as much breathing trouble as morphine might at similar doses. This makes it an intriguing subject for researchers exploring pain management strategies.

Who it's for

Researchers studying advanced pain management solutions
Biohackers interested in natural compounds with strong effects
People curious about unique, nature-derived substances

Probably not for you if…

Anyone without a background in peptide research
Individuals looking for over-the-counter pain solutions
Those concerned about the ethical use of animal-derived substances

Editorial summary for research context · Not medical advice

Mechanism of Action

Dermorphin is a naturally-occurring opioid heptapeptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) first isolated from the skin of Phyllomedusa frogs native to South America. It is a highly selective μ-opioid receptor agonist with potency that has been reported as orders of magnitude greater than morphine on a molar basis in animal models. The unusual D-alanine residue confers resistance to enzymatic degradation and crosses the blood-brain barrier more readily than endogenous enkephalins. Dermorphin has been detected as a doping agent in equine racing and is considered a controlled substance in human and animal sport contexts.

Researched Benefits

Analgesia research (preclinical)

Rodent models demonstrate potent and long-lasting antinociception via μ-opioid receptor agonism, with reduced respiratory depression relative to morphine at equi-analgesic doses in some studies.

[Broccardo et al. 1981]
[Negri et al. 2000]

μ-receptor selectivity

Binding studies indicate higher μ vs δ/κ receptor selectivity compared with classic opioid references, making dermorphin a useful research probe for μ-pathway biology.

[Amiche et al. 1989]

Research Protocols

The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.

Research use only

Dosage: 0 mcg
Frequency: not recommended for self-administration
Timing: n/a
Cycle: 0 weeks

Dermorphin is a potent μ-opioid agonist. No established self-administration protocol exists. Published research is preclinical and conducted under tightly controlled laboratory conditions. Considered a controlled substance in many jurisdictions and banned in human and equine sport.

Reported Side Effects

Respiratory depression — a defining risk of potent μ-opioid agonists; can be fatal at supratherapeutic doses
Sedation, pruritus, constipation, nausea (classic opioid profile)
Physical dependence and withdrawal with repeated administration
High potency increases overdose risk versus conventional opioids
Tolerance develops rapidly with repeated dosing

Contraindications

Any self-administration outside a controlled research setting
Pregnancy and lactation
Personal or family history of opioid use disorder
Respiratory disease, sleep apnea, or compromised airway
Concurrent CNS depressant use (benzodiazepines, alcohol, sedatives) — additive respiratory risk
Banned in WADA-governed sport and equine racing

Vendor Pricing

No tracked vendors carry this peptide yet. Check back as we add more affiliate partners.

Gear + Companions

Reconstitution supplies and research-backed supplement companions for Dermorphin. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.

Gear you'll need

· Reconstitution + storage essentials

Bacteriostatic Water 30mL (0.9% Benzyl Alcohol)
Empower Pharmacy / generic medical supply
Reconstitutes every lyophilized peptide. 28-day viability refrigerated.
View at Pantheon →
Insulin Syringes 31G × 5/16" × 0.5mL (100 count)
EasyTouch
31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.
Buy on Amazon →
Alcohol Prep Pads (Sterile, 200 count)
Dynarex
Sterile 70% IPA prep pads — one per vial stopper + one per injection site.
Buy on Amazon →
1-Quart Sharps Disposal Container
BD / Becton Dickinson
FDA-cleared sharps container — pharmacies won't accept improvised disposal.
Buy on Amazon →

As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines

Research Papers

Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin
Broccardo M, et al. · British Journal of Pharmacology · 1981
PubMed 6121605 →
Dermorphin and its analogues: multiple receptors and multiple actions
Negri L, et al. · Biopolymers · 2000
PubMed 11054570 →

Dermorphin

Mechanism of Action